Professor Gill is Co-Director of the Gene Medicine Research Group, which is investigating the potential for gene therapy to treat acute and chronic lung diseases such as cystic fibrosis, emphysema, asthma, lung cancer and acute respiratory distress syndrome (ARDS). The group was the first to demonstrate that the fundamental defect in CF could be corrected by gene therapy and has subsequently run clinical trials in CF patients. Together with colleagues at the University of Edinburgh and Imperial College London the group formed the UK Cystic Fibrosis Gene Therapy Consortium, which is aimed at making gene therapy a reality for patients with CF.
- Cystic fibrosis
- Treatment for cystic fibrosis lung disease
- Uses of gene therapy to treat disease
- Use of DNA in human clinical trials
Dr Gill has experience of working with the media, including live radio interviews and press interviews.